Biphasic Insulin Aspart 30, 50, 70
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Biphasic Insulin Aspart 30, 50, 70, covering 2017-01-06 to 2017-01-06. Get the full timeline:
Most recent: Clinical Trial Update: Comparison of the Pharmacodynamics and Pharmacokinetics of Biphasic Insulin Aspart 30, 50, 70 and Insulin Aspart in Subjects With Type 1 Diabetes [Phase 1]